Patent Ductus Arteriosus Clinical Trials: Lessons Learned and Future Directions
The identification of an optimal management strategy for the patent ductus arteriosus (PDA) in the context of extreme prematurity remains elusive. Observational studies have reported a persistent association between PDA and neonatal adverse outcomes, but by and large, no clinical trial, to date, has...
Main Authors: | Aisling Smith, Afif EL-Khuffash |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | Children |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9067/8/1/47 |
Similar Items
-
Practice for preterm patent ductus arteriosus; focusing on the hemodynamic significance and the impact on the neonatal outcomes
by: Jin A Lee
Published: (2019-07-01) -
Velocity time integral for right upper pulmonary vein in VLBW infants with patent ductus arteriosus
by: Gianluca Lista, et al. -
Perinatal risk factors of symptomatic preterm patent ductus arteriosus and secondary ligation
by: Jin A Lee, et al.
Published: (2020-08-01) -
Physiological marker and surgical ligation of patent ductus arteriosus in neonates
by: Behrouz Banieghbal
Published: (2016-01-01) -
Transcatheter Closure of Patent Ductus Arteriosus in Infants With Weight Under 1,500 Grams
by: Alain Fraisse, et al.
Published: (2020-09-01)